+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuroendocrine Carcinoma"

Neuroendocrine Tumor Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumor Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 383 Pages
  • Global
From
Neuroendocrine Tumors Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 171 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report 2025 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
Neuroendocrine Carcinoma Market Report and Forecast (2025-2034) - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report and Forecast (2025-2034)

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Neuroendocrine Tumor Market Report and Forecast 2025-2034 - Product Thumbnail Image

Neuroendocrine Tumor Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Gastroenteropancreatic Neuroendocrine Tumors Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Gastroenteropancreatic Neuroendocrine Tumors Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035

  • Report
  • July 2025
  • Global
From
Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastric Neuroendocrine Tumor Market Report and Forecast 2025-2034 - Product Thumbnail Image

Gastric Neuroendocrine Tumor Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035 - Product Thumbnail Image

Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035

  • Report
  • September 2025
  • 313 Pages
  • Global
From
Targeted Alpha Therapies for Cancer Treatment: Global Market - Product Thumbnail Image

Targeted Alpha Therapies for Cancer Treatment: Global Market

  • Report
  • September 2025
  • 81 Pages
  • Global
From
Somatostatin Analogs Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide), Application (Acromegaly, NET), End-use (Hospitals, Clinics), and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Somatostatin Analogs Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide), Application (Acromegaly, NET), End-use (Hospitals, Clinics), and Region with Growth Forecasts, 2025-2030

  • Report
  • May 2025
  • 90 Pages
  • Global
From
Peptide Drug Conjugates Market Size, Share & Trends Analysis Report by Product (Illuccix, Pluvicto, CBX-12, Pipeline Products), Type (Diagnostic, Therapeutic), and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Peptide Drug Conjugates Market Size, Share & Trends Analysis Report by Product (Illuccix, Pluvicto, CBX-12, Pipeline Products), Type (Diagnostic, Therapeutic), and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 100 Pages
  • Global
From
Somatostatin Analogs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Somatostatin Analogs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Lutetium-177 Market - Global Forecast 2026-2032 - Product Thumbnail Image

Lutetium-177 Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Long-acting Somatostatin Analogues Market - Global Forecast 2026-2032 - Product Thumbnail Image

Long-acting Somatostatin Analogues Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Manmade Version of Somatostatin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Manmade Version of Somatostatin Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Targeted SSTR Radionuclide Drug Conjugates Market - Global Forecast 2026-2032 - Product Thumbnail Image

Targeted SSTR Radionuclide Drug Conjugates Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
Zollinger-Ellison Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Zollinger-Ellison Syndrome Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 368 Pages
  • Global
From
Loading Indicator

Neuroendocrine carcinoma (NEC) is a rare type of cancer that affects the neuroendocrine system, which is responsible for the production of hormones. It is a type of cancer that is often difficult to diagnose and treat. Treatment options for NEC include surgery, chemotherapy, radiation therapy, and targeted therapies. Oncology drugs are used to treat NEC, and they can be used alone or in combination with other treatments. These drugs can help to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of recurrence. The Neuroendocrine Carcinoma market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of NEC, the development of new treatments, and the increasing availability of targeted therapies. Companies in the market include Novartis, Pfizer, Merck, AstraZeneca, and Roche. Show Less Read more